ArticleThe pharmacogenomics journal2004
Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs.
Article in The pharmacogenomics journal, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Improving the Efficiency and Quality of the Value Assessment Process for Companion Diagnostic Tests: The Companion test Assessment Tool (CAT).Journal of managed care & specialty pharmacy · 2015Pooled it
- Article
- Pharmacogenetic information in Swiss drug labels - a systematic analysis.The pharmacogenomics journal · 2021Article
- Comparing cytochrome P450 pharmacogenetic information available on United States drug labels and European Union Summaries of Product Characteristics.The pharmacogenomics journal · 2017Article
- Screening for 392 polymorphisms in 141 pharmacogenes.Biomedical reports · 2014Article
- An evaluation of pharmacogenomic information provided by five common drug information resources.Journal of the Medical Library Association : JMLA · 2014Article
- Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information.Journal of personalized medicine · 2013Article
- Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists.Pharmacogenomics · 2013Article
- Insurance coverage policies for personalized medicine.Journal of personalized medicine · 2012Article
- Survey of US public attitudes toward pharmacogenetic testing.The pharmacogenomics journal · 2012Article
- Feasibility of incorporating genomic knowledge into electronic medical records for pharmacogenomic clinical decision support.BMC bioinformatics · 2010Article
- Pharmacogenomics, evidence, and the role of payers.Public health genomics · 2009Article
- [Implications of pharmacogenetics in every-day practice].Der Internist · 2005Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
15483659What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.